全文获取类型
收费全文 | 923篇 |
免费 | 57篇 |
国内免费 | 22篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 71篇 |
妇产科学 | 8篇 |
基础医学 | 91篇 |
口腔科学 | 43篇 |
临床医学 | 72篇 |
内科学 | 156篇 |
皮肤病学 | 27篇 |
神经病学 | 44篇 |
特种医学 | 232篇 |
外科学 | 68篇 |
综合类 | 35篇 |
预防医学 | 59篇 |
眼科学 | 6篇 |
药学 | 21篇 |
肿瘤学 | 68篇 |
出版年
2018年 | 10篇 |
2017年 | 6篇 |
2016年 | 10篇 |
2015年 | 11篇 |
2014年 | 16篇 |
2013年 | 11篇 |
2012年 | 10篇 |
2011年 | 20篇 |
2010年 | 27篇 |
2009年 | 23篇 |
2008年 | 28篇 |
2007年 | 26篇 |
2006年 | 27篇 |
2005年 | 23篇 |
2004年 | 22篇 |
2003年 | 17篇 |
2002年 | 12篇 |
2001年 | 14篇 |
2000年 | 13篇 |
1999年 | 21篇 |
1998年 | 40篇 |
1997年 | 44篇 |
1996年 | 42篇 |
1995年 | 36篇 |
1994年 | 25篇 |
1993年 | 32篇 |
1992年 | 22篇 |
1991年 | 21篇 |
1990年 | 16篇 |
1989年 | 30篇 |
1988年 | 32篇 |
1987年 | 45篇 |
1986年 | 26篇 |
1985年 | 18篇 |
1984年 | 9篇 |
1983年 | 14篇 |
1982年 | 16篇 |
1981年 | 21篇 |
1980年 | 18篇 |
1979年 | 8篇 |
1978年 | 8篇 |
1977年 | 9篇 |
1976年 | 21篇 |
1975年 | 12篇 |
1934年 | 4篇 |
1927年 | 6篇 |
1926年 | 6篇 |
1912年 | 5篇 |
1910年 | 4篇 |
1909年 | 5篇 |
排序方式: 共有1002条查询结果,搜索用时 15 毫秒
41.
42.
Phosphoglucomutase 1, an enzyme mapping on the short arms of chromosome 1, is constantly missing in the leukemic cell line K-562 in spite of the presence of three No. 1 chromosomes. In the present work, a subclone of the cell line, K-562 (S)P, is described, where the enzyme can be demonstrated, thus excluding a small deletion as the cause for the lack of expression of phosphoglucomutase 1. The relationship between the presence of the enzyme and the karyotype changes in this subclone is analyzed. Addition of several inducers to the standard K-562 line failed to elicit expression of the enzyme. 相似文献
43.
44.
Battistini S Giannini F Greco G Bibbò G Ferrera L Marini V Causarano R Casula M Lando G Patrosso MC Caponnetto C Origone P Marocchi A Del Corona A Siciliano G Carrera P Mascia V Giagheddu M Carcassi C Orrù S Garrè C Penco S 《Journal of neurology》2005,252(7):782-788
Amyotrophic Lateral Sclerosis (ALS), the most common form among motoneuron diseases, is characterized by a progressive neurodegenerative process involving motor neurons in the motor cortex, brain stem and spinal cord. Sporadic (SALS) accounts for the majority of patients but in about 10% of ALS cases the disease is inherited (FALS), usually as an autosomal dominant trait.In the present study we show the results of a referred based multicenter study on the distribution of SOD1 gene mutations in the largest cohort of Italian ALS patients described so far. Two hundred and sixty-four patients (39 FALS and 225 SALS) of Italian origin were studied. In 7 out of 39 FALS patients we found the following SOD1 gene mutations: i) a new G12R missense mutation in exon 1, found in a patient with a slowly progressive disease course; ii) the G41S mutation, in four unrelated patients with rapidly progressive course complicated with cognitive decline in two of them; iii) the L114F mutation, in a patient with a slowly progressive phenotype; iv) the D90A mutation, in a heterozygous patient with atypical phenotype. In addition, in one SALS patient a previously reported synonymous variant S59S was identified. In 17 (3 FALS and 14 SALS) out of 264 patients (6.4 %) the polymorphism A-->C at position 34 of intron 3 (IVS3: + 34 A-->C) was found, and in one FALS patient a novel variant IVS3 + 62 T-->C was identified.The frequency of SOD1 gene mutations (17.9 %) in FALS cases was comparable with that found in other surveys with a similar sample size of ALS cases. No SOD1 gene mutations have been identified in SALS cases. Within FALS cases, The most frequent mutation was the G41S identified in four FALS. 相似文献
45.
Percutaneous CT-guided 103Pd implantation for the medically inoperable patient with T1N0M0 non-small cell lung cancer: a case report 总被引:3,自引:0,他引:3
Three patients with early-stage T1N0M0 non-small cell lung cancer (NSCLC) who had medical contraindications for standard surgical resection were treated with CT-guided percutaneous implantation of (103)Pd seeds. The technique was proven safe in this small subset of patients without any complications related to the procedure or during short-term follow-up. 相似文献
46.
47.
Grönefeld GC Israel CW Padmanabhan V Koehler J Cuijpers A Hohnloser SH;WorldWide Gem DR Study Group 《Pacing and clinical electrophysiology : PACE》2002,25(12):1708-1714
Reviews of stored electrograms from ICDs revealed a 5-30% incidence of short-long-short intervals preceding the onset of recurrent ventricular tachyarrhythmias. Rate stabilization by dedicated antibradycardia pacing algorithms has, therefore, been suggested to prevent onset of pause dependent tachyarrhythmias. However, the clinical efficacy of this approach has not been studied systematically. In a prospective multicenter crossover study, patients were randomized to activation or deactivation of an implemented ventricular rate stabilization algorithm (VRS) after first implant of a dual chamber ICD. After 3 months, all patients were crossed over to the alternate programming. The rate of appropriate spontaneous VA episodes was compared between VRS On and VRS Off. Stored electrograms were reviewed for evaluation of the mode of onset of tachyarrhythmias. Overall efficacy analysis was based on 309 patients enrolled in the study. Forty percent (124/309) of the patients experienced 4,973 VA episodes. Based on an intention-to-treat analysis, VRS Off and On arrhythmia incidence was 10.2 and 6.6 normalized to 3 months, respectively (risk reduction 35%; P = 0.18) On an on-treatment basis, a reduction from 9.0 episodes to 8.1 episodes (10% risk reduction, P = 0.24) was seen. In an extended Cox model adjusting for confounding variables, the relative risk for recurrent episodes was 0.92 during VRS On compared to Off (95% CI: 0.58-1.48; P = 0.74). During VRS Off, pause dependent onset was documented in only 36 (8%) of 427 visually analyzed episodes. There was no significant reduction in the incidence of recurrent ventricular tachyarrhythmias with VRS On compared to the Off programming in this prospective study. 相似文献
48.
Giorgio?PerilongoEmail author Maria?Luisa?Garrè Felice?Giangaspero 《Child's nervous system》2003,19(4):197-203
DISCUSSION: The leptomeningeal dissemination (LMD) of low-grade gliomas (LGGs) is reported in clinical neuro-oncology practice more and more frequently. It is estimated that 5% of all childhood LGGs present LMD at diagnosis and 7-10% at the time of progression. LMD has been reported in association with almost all the known subtypes of LGGs. Furthermore, "unusual " LGGs can be encountered among slow-growing brain neoplasm capable of LMD, which cannot comfortably be included in the present WHO brain tumour classification. The biological, genetic and clinical characteristics that seem to favour LMD are far from being understood. Similarly, the clinical profile of those children with disseminated LGGs has not yet been firmly established. Young, non-neurofibromatosis type 1 boys with large hypothalamic-chiasmatic pilocytic astrocytomas seem to be at increased risk of LMD. The neuroradiological appearance of LMD in childhood LGGs is similar to that observed in malignant tumours, except for those cases characterised by multiple superficial non-enhancing cystic lesions, which seem to be almost exclusively associated with a type of slow-growing not yet fully identified brain stem or spinal tumour. No firm guidelines for the treatment of these diseases are yet available, mostly due to the rarity of this condition and the existing uncertainties regarding their natural clinical history. CONCLUSION: The evidence of LMD in children with LGGs does not seem to have a negative impact on patients' long-term outcome. 相似文献
49.